Skip to Content

Captique Approval History

FDA Approved: Yes (First approved November 12, 2004)
Brand name: Captique
Generic name: dermal filler
Dosage form: Injectable Gel
Company: Inamed Corp / Genzyme Corp
Treatment for: Wrinkle Correction

Captique is a non-animal stabilized hyaluronic acid dermal filler indicated for the correction of moderate to severe facial wrinkles.

Development History and FDA Approval Process for Captique

DateArticle
Dec  2, 2004Approval Captique Inamed Corp / Genzyme Corp - Treatment for Facial Wrinkle Correction

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide